Home New Customer? Create Account
Member Login:

Borrelia Assay Kits

Borrelia Assay Kits

The anti-borrelia ELISA kits are intended for the detection of IgG and IgM antibodies to the pathogenic borrelia strains (B. afzelii, B. garinii and B. burgdorferi sensu stricto) in human serum, cerebrospinal fluid and synovial fluid.  The detection of antibodies is one of the laboratory tests that helps to diagnose Lyme Disease (LD). The anti-Borelia LIA kits are used for the qualitative detection of Anaplasma phagocytophila in human serum for indicative diagnostics of human granulocytic anaplasmosis (HGA).

Anti-Borrelia IgM antibodies are detectable 3 weeks after infection with its maximum during the sixth week. Subsequently, the titer of IgM antibodies decreases and IgG antibodies prevail. The detection of anti-borrelia antibodies is very important at the early stage of the disease because the typical symptoms are present only in a certain proportion of patients. The clinical symptoms of LD are similar to the symptoms of other diseases. Therefore, the serology is also of use in differential diagnosis of neuroinfections, arthropathies, carditis and skin diseases. 

Please see below for an overview of the anti-Borrelia kits.

Cat# Anti-Borrelia Product Method Evaluation Tests Samples Sensitivity / Specificity
ODZ-282 recombinant IgG + VlsE ELISA semiquantitative 96 serum, cerebrospinal fluid 95% / 99%
ODZ-281 recombinant IgM ELISA semiquantitative 96 serum, cerebrospinal fluid 99% / 97%
ODZ-172 recombinant IgG (CSF) + VlsE ELISA qualitative 96 serum, cerebrospinal fluid, synovial fluid 95% / 99%
ODZ-173 recombinant IgM (CSF) ELISA qualitative 96 serum, cerebrospinal fluid, synovial fluid 99% / 97%
ODZ-316IgG LIA qualitative 16 serum 100% / 98%
ODZ-317 IgM LIA qualitative 16 serum 97% / 98%